DK173674B1 - Anti-allergiske præparater indeholdende N-heterocyclyl-4-piperidinaminer, N-heterocyclyl-4-piperidinaminer til brug som antiallergikum og hidtil ukendte N-heterocyclyl-4-piperidinaminer samt fremgangsmåde til fremstilling deraf - Google Patents

Anti-allergiske præparater indeholdende N-heterocyclyl-4-piperidinaminer, N-heterocyclyl-4-piperidinaminer til brug som antiallergikum og hidtil ukendte N-heterocyclyl-4-piperidinaminer samt fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK173674B1
DK173674B1 DK198700541A DK54187A DK173674B1 DK 173674 B1 DK173674 B1 DK 173674B1 DK 198700541 A DK198700541 A DK 198700541A DK 54187 A DK54187 A DK 54187A DK 173674 B1 DK173674 B1 DK 173674B1
Authority
DK
Denmark
Prior art keywords
alkyl
furanyl
formula
methyl
substituted
Prior art date
Application number
DK198700541A
Other languages
Danish (da)
English (en)
Other versions
DK54187D0 (da
DK54187A (da
Inventor
Frans Eduard Janssens
Joseph Leo Ghislanus Torremans
Jozef Francis Hens
Jozef Jan Pieter Heykants
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK54187D0 publication Critical patent/DK54187D0/da
Publication of DK54187A publication Critical patent/DK54187A/da
Application granted granted Critical
Publication of DK173674B1 publication Critical patent/DK173674B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198700541A 1986-02-03 1987-02-02 Anti-allergiske præparater indeholdende N-heterocyclyl-4-piperidinaminer, N-heterocyclyl-4-piperidinaminer til brug som antiallergikum og hidtil ukendte N-heterocyclyl-4-piperidinaminer samt fremgangsmåde til fremstilling deraf DK173674B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82549186A 1986-02-03 1986-02-03
US82549186 1986-02-03

Publications (3)

Publication Number Publication Date
DK54187D0 DK54187D0 (da) 1987-02-02
DK54187A DK54187A (da) 1987-08-04
DK173674B1 true DK173674B1 (da) 2001-06-05

Family

ID=25244134

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700541A DK173674B1 (da) 1986-02-03 1987-02-02 Anti-allergiske præparater indeholdende N-heterocyclyl-4-piperidinaminer, N-heterocyclyl-4-piperidinaminer til brug som antiallergikum og hidtil ukendte N-heterocyclyl-4-piperidinaminer samt fremgangsmåde til fremstilling deraf

Country Status (26)

Country Link
EP (1) EP0232937B1 (xx)
JP (2) JPH0794393B2 (xx)
CN (1) CN1018614B (xx)
AT (1) ATE79620T1 (xx)
AU (1) AU583706B2 (xx)
CA (1) CA1327579C (xx)
CY (1) CY1865A (xx)
DE (1) DE3781173T2 (xx)
DK (1) DK173674B1 (xx)
EG (1) EG17993A (xx)
ES (1) ES2052544T3 (xx)
FI (1) FI870448A (xx)
GR (1) GR3006158T3 (xx)
HK (1) HK114695A (xx)
HU (1) HU201067B (xx)
IE (1) IE60885B1 (xx)
IL (1) IL81448A (xx)
MA (1) MA20868A1 (xx)
NO (1) NO870407L (xx)
NZ (1) NZ219165A (xx)
PH (1) PH24738A (xx)
PT (1) PT84234B (xx)
TN (1) TNSN87015A1 (xx)
ZA (1) ZA87744B (xx)
ZM (1) ZM1287A1 (xx)
ZW (1) ZW2087A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
US4988689A (en) * 1987-07-01 1991-01-29 Janssen Pharmaceutica N.V. ((Pharmacologically active bicyclic heterocyclic)methyl and -heteroatom) substituted hexahydro-1H-azepines and pyrrolidines
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
IT1229231B (it) * 1989-05-08 1991-07-26 Dompe Farmaceutici Spa Aminoimidazopiridine farmacologicamente attive
CA2043564A1 (en) * 1990-07-06 1992-01-07 Alfons G. M. De Knaep 3-[(5-methyl-2-furanyl)methyl]-n-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
AU730229B2 (en) * 1992-09-03 2001-03-01 Sepracor, Inc. Use of norastemizole for the treatment of allergic disorders
ES2210957T3 (es) * 1992-09-03 2004-07-01 Sepracor Inc. Composiciones farmaceuticas que contienen norastemizol.
CA2161876A1 (en) * 1993-05-20 1994-12-08 Den-Ichi Momose 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds
TW429256B (en) * 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
NZ517472A (en) * 1997-03-26 2003-08-29 Sepracor Inc Lactose free norastemizole formulations with improved stability
US5817823A (en) * 1997-04-17 1998-10-06 Sepracor Inc. Method for synthesizing 2-substituted imidazoles
AU778218B2 (en) 1999-06-28 2004-11-25 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
EE04590B1 (et) * 1999-06-28 2006-02-15 Janssen Pharmaceutica N.V. Respiratoorse süntsütiaalviiruse replikatsiooni inhibiitorid, nende kasutamine ja valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod ning produkt
BR0011997A (pt) 1999-06-28 2002-03-05 Janssen Pharmaceutica Nv Inibidores da replicação do vìrus sincicial respiratório
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
WO2004113297A2 (en) * 2003-06-24 2004-12-29 Neurosearch A/S Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
PL1706403T3 (pl) 2003-12-22 2012-07-31 K U Leuven Res & Development Związki imidazo[4,5-c]pirydynowe i sposoby leczenia przeciwwirusowego
DE602005013580D1 (de) 2004-12-21 2009-05-07 Leuven K U Res & Dev Imidazoä4,5-cüpyridinverbindung und verfahren zur antiviralen behandlung
JP5065908B2 (ja) * 2004-12-24 2012-11-07 プロシディオン・リミテッド Ｇタンパク質結合受容体作動薬
ES2350647T3 (es) 2005-03-08 2011-01-25 Janssen Pharmaceutica Nv Derivados de diaza-espiro-[4.4]-nonano como antagonistas de neuroquininas (nk1).
TWI360549B (en) 2006-07-07 2012-03-21 Gilead Sciences Inc Novel pyridazine compound and use thereof
UA99466C2 (xx) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Кристалічна сполука піридазину$кристаллическое соединение пиридазина
CA2737694C (en) * 2008-09-26 2013-07-02 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
IN156065B (xx) * 1982-07-12 1985-05-04 Janssen Pharmaceutica Nv
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
PL144514B1 (en) * 1984-01-09 1988-06-30 Janssen Pharmaceutica Nv Method of obtaining novel derivatives of n-/4-piperidinolo/-2-imidazoloamine
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines

Also Published As

Publication number Publication date
ZW2087A1 (en) 1988-08-31
DE3781173D1 (de) 1992-09-24
FI870448A0 (fi) 1987-02-02
HUT44544A (en) 1988-03-28
PT84234A (en) 1987-03-01
PH24738A (en) 1990-10-01
NO870407L (no) 1987-08-04
JPH0794393B2 (ja) 1995-10-11
IL81448A0 (en) 1987-09-16
DK54187D0 (da) 1987-02-02
JPH0819126B2 (ja) 1996-02-28
IL81448A (en) 1990-09-17
IE870258L (en) 1987-08-03
PT84234B (pt) 1989-09-14
ES2052544T3 (es) 1994-07-16
IE60885B1 (en) 1994-08-24
CN87100563A (zh) 1987-08-19
CA1327579C (en) 1994-03-08
EP0232937A3 (en) 1988-04-06
HU201067B (en) 1990-09-28
DK54187A (da) 1987-08-04
JPH07179458A (ja) 1995-07-18
TNSN87015A1 (fr) 1990-01-01
FI870448A (fi) 1987-08-04
HK114695A (en) 1995-07-21
NO870407D0 (no) 1987-02-02
JPS62215575A (ja) 1987-09-22
EP0232937B1 (en) 1992-08-19
GR3006158T3 (xx) 1993-06-21
NZ219165A (en) 1990-04-26
ZA87744B (en) 1988-10-26
EP0232937A2 (en) 1987-08-19
EG17993A (en) 1991-08-30
AU6821887A (en) 1987-08-06
DE3781173T2 (de) 1992-12-17
CN1018614B (zh) 1992-10-14
CY1865A (en) 1996-04-05
AU583706B2 (en) 1989-05-04
ATE79620T1 (de) 1992-09-15
ZM1287A1 (en) 1988-08-29
MA20868A1 (fr) 1987-10-01

Similar Documents

Publication Publication Date Title
DK173674B1 (da) Anti-allergiske præparater indeholdende N-heterocyclyl-4-piperidinaminer, N-heterocyclyl-4-piperidinaminer til brug som antiallergikum og hidtil ukendte N-heterocyclyl-4-piperidinaminer samt fremgangsmåde til fremstilling deraf
US4835161A (en) Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
US7572796B2 (en) Substituted indoles
HU207514B (en) Process for producing 4-piperidiyl-amine derivatives containing 5-membered heterocyclic group on the amine-nitrogen and pharmaceutical compositions containing them
HU187329B (en) Process for peparing %-/1-piperidyl-alkyl/-4h-pyrido/1,2-a/pyrimidin-4-one derivatives
DK165370B (da) Benzoxazol-, benzothiazol- og thiazolopyridinaminderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
JPH0613511B2 (ja) 新規１，２‐ベンズイソキサゾール‐３‐イル及び１，２‐ベンズイソチアゾール‐３‐イル誘導体
JPH0768240B2 (ja) ４―〔（二環式複素環）―メチル及びヘテロ〕ピペリジン類及びその製法
NZ231788A (en) Pyrimidinone derivatives and pharmaceutical derivatives
CA2040086C (en) Novel 2,9-disubstituted-4h-pyrido[1,2-a]pyrimidin-4-ones
NZ231787A (en) Compounds containing at least 3 separate nitrogen containing rings; anti allergic compositions
EP0184258B1 (en) Novel derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
AU702931B2 (en) Antipsychotic 4-(1H-indolyl-1-yl)-1-substituted piperidine derivatives
JPH01228986A (ja) ［（５（６）（１ｈ―アゾール―１―イルメチル）ベンズイミダゾール］カーバメート
DK169761B1 (da) N-(4-piperidinyl)substituerede bicyclisk kondenserede 2-imidazolaminderivater, fremgangsmåde til fremstilling deraf og præparater indeholdende disse derivater
NO174851B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv hydroksyalkylfuranylderivater
KR20010071844A (ko) 의약으로서의 트리사이클릭 δ3-피페리딘
CN113166160B (zh) 作为毒蕈碱型m1受体正向别构调节剂的吡咯并哒嗪衍生物
DK169547B1 (da) 3-piperidinyl-indazolderivater, fremgangsmåde til fremstilling deraf, præparater indeholdende disse samt anvendelse af derivaterne til fremstilling af farmaceutiske præparater
KR950010186B1 (ko) N-헤테로사이클릴-4-피페리딘아민 유도체
HU196994B (en) Process for producing pyridine derivatives and pharmaceuticals comprising same
NO173866B (no) Mellomprodukter for fremstilling av ((4-(4-(-4-fenyl-1-piperazinyl)fenoksymetyl)-1,3-dioksolan-2-yl)-metyl)-1h-imidazoler og 1h-1,2,4-triazoler

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired